New hope for kids with tough leukemia: drug combo shows promise
NCT ID NCT04996160
First seen Apr 18, 2026 · Last updated May 08, 2026 · Updated 5 times
Summary
This early-phase study tested a drug called palbociclib combined with standard chemotherapy in children whose acute lymphoblastic leukemia (ALL) had returned or stopped responding to treatment. Only 2 children took part, and the main goal was to find a safe dose and check for side effects. The study also looked at how the drug affects leukemia cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lucile Packard Children's Hospital Stanford
Stanford, California, 94304, United States
Conditions
Explore the condition pages connected to this study.